Zobrazeno 1 - 10 of 229 pro vyhledávání: '"SB Gordon"'
2
In depth analysis of patients with severe SARS-CoV-2 in sub-Saharan Africa demonstrates distinct clinical and immunological profiles
Autor: E Chinyama, Kc Jambo, Ben Morton, Raphael Kamng'ona, Grace Katha, O Kanjewa, S Sichone, C Ntwea, D Tembo, B Denis, E Nsomba, A Chingota, S Kaimba, Kelvin Mponda, M Mkandawire, E Storey, James Jafali, Clinical, Catherine Anscombe, Jennifer E. Cornick, S Lissauer, V Nyasulu, H Thole, J Phulusa, Chimota Phiri, Khuzwayo C. Jere, Ndaziona Peter Banda, P Mwenechanya, M Chaponda, L Mvaya, James Nyirenda, Sb Gordon, J Gondwe, Ks Mndolo, P Kambiya, V Kaudzu, Pi Iroh Tam, C Van Der Veer, Myr Henrion, P Mandala, C Mhango, S Nthala, Jane Mallewa, Td Swarthout, Tamara Phiri, P MacPherson, B Chinoko, B Freyne, Jamie Rylance, A Lakudzala, Jonathan Mandolo, A Ahmadu, Prisca Matambo, C Masesa, Comfort Brown, D Matchado, J Chirombo, Kg Barnes, N Bondera, A Zuza, M Gmeiner, A Chande, Hc Mwandumba, L Keyala
Publikováno v: Nature Communications
medRxiv
article-version (status) pre
article-version (number) 2
Although the COVID-19 pandemic has left no country untouched there has been limited research to understand clinical and immunological responses in African populations. Here we characterise patients hospitalised with suspected (PCR-negative/IgG-positi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b2f497b44cd8a58a35b9eabb7c06cc5
https://pubmed.ncbi.nlm.nih.gov/34117221
Zobrazit plný text záznamu
7
Akademický článek
Essential role of proline synthesis and the one-carbon metabolism pathways for systemic virulence of Streptococcus pneumoniae .
Autor: Ramos-Sevillano E; Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, Rayne Institute, London, United Kingdom., Ercoli G; Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, Rayne Institute, London, United Kingdom., Betts M; Research Department of Infection, Division of Infection and Immunity, University College London, Rayne Institute, London, United Kingdom., Guerra-Assunção JA; Great Ormond Street Institute of Child Health, University College London (UCL), London, United Kingdom., Iverson A; Department of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Frank M; Department of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Partridge F; Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, Rayne Institute, London, United Kingdom.; School of Life Sciences, University of Westminster, London, United Kingdom., Lo SW; Parasites and Microbes, Wellcome Sanger Institute, Hinxton, United Kingdom.; Milner Centre for Evolution, Department of Life Sciences, University of Bath, Bath, United Kingdom., Fernandes VE; Faculdade de Medicina e Ciências Biomédicas and ABC-RI. Faro, Faro, Portugal., Nasher F; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom., Wall E; Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, Rayne Institute, London, United Kingdom., Wren B; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom., Gordon SB; Malawi-Liverpool-Wellcome Trust Clinical Research Programme Blantyre, Blantyre, Malawi., Ferreira DM; Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Heyderman R; Research Department of Infection, Division of Infection and Immunity, University College London, Rayne Institute, London, United Kingdom., Rosch J; Department of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Brown JS; Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, Rayne Institute, London, United Kingdom.
Publikováno v: MBio [mBio] 2024 Oct 18, pp. e0175824. Date of Electronic Publication: 2024 Oct 18.
Zobrazit plný text záznamu
8
Akademický článek
Inflammation of the nasal mucosa is associated with susceptibility to experimental pneumococcal challenge in older adults.
Autor: Urban BC; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK. Electronic address: Britta.urban@paediatrics.ox.ac.uk., Gonçalves ANA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Loukov D; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK., Passos FM; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK., Reiné J; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Gonzalez-Dias P; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Solórzano C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Mitsi E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Nikolaou E; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK; Infection, Immunity and Global Health, Murdoch Children's Research Institute, Parkville, Victoria, Australia; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria, Australia., O'Connor D; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Collins AM; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK; University Hospital Aintree, Liverpool University Hospitals Trust, Liverpool, UK., Adler H; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK., Pollard A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Rylance J; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK., Gordon SB; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK; Malawi-Liverpool-Wellcome Clinical Research Programme, Blantyre, Malawi., Jochems SP; Leiden University Centre for Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands., Nakaya HI; Hospital Israelita Albert Einstein, São Paulo, Brazil; Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil., Ferreira DM; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK. Electronic address: Daniela.ferreira@paediatrics.ox.ac.uk.
Publikováno v: Mucosal immunology [Mucosal Immunol] 2024 Oct; Vol. 17 (5), pp. 973-989. Date of Electronic Publication: 2024 Jun 29.
Zobrazit plný text záznamu
9
Akademický článek
RSV and rhinovirus increase pneumococcal carriage acquisition and density, whereas nasal inflammation is associated with bacterial shedding.
Autor: Mitsi E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, UK; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK. Electronic address: elena.mitsi@paediatrics.ox.ac.uk., Nikolaou E; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC 3052, Australia., Goncalves A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, UK; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK., Blizard A; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK., Hill H; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK., Farrar M; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK., Hyder-Wright A; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK., Akeju O; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, UK., Hamilton J; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK., Howard A; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK., Elterish F; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, UK., Solorzano C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, UK; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK., Robinson R; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK., Reiné J; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, UK; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK., Collins AM; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK., Gordon SB; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK; Malawi Liverpool Wellcome-Trust Programme, Queen Elizabeth Central Hospital Campus, P.O. Box 30096, Blantyre, Malawi., Moxon RE; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, UK., Weiser JN; Department of Microbiology, New York University School of Medicine, New York, NY 10016, USA., Bogaert D; Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK; Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital, University Medical Centre Utrecht, 3584 EA Utrecht, the Netherlands., Ferreira DM; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, UK; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK. Electronic address: daniela.ferreira@paediatrics.ox.ac.uk.
Publikováno v: Cell host & microbe [Cell Host Microbe] 2024 Sep 11; Vol. 32 (9), pp. 1608-1620.e4. Date of Electronic Publication: 2024 Aug 23.
Zobrazit plný text záznamu
10
Akademický článek
Review of Current Tuberculosis Human Infection Studies for Use in Accelerating Tuberculosis Vaccine Development: A Meeting Report.
Autor: Balasingam S; Infectious Disease, Wellcome Trust, London, United Kingdom., Dheda K; Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and University of Cape Town (UCT) Lung Institute and South African Medical Research Council/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, South Africa., Fortune S; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts., Gordon SB; Clinical Experimental Medicine, Malawi Liverpool Wellcome Programme, Blantyre., Hoft D; Departments of Internal Medicine and Molecular Microbiology & Immunology, Saint Louis University of Medicine, Missouri., Kublin JG; Cancer Center, Vaccine and Infectious Disease Division, Fred Hutchinson Institute, Seattle, Washington., Loynachan CN; Infectious Disease, Wellcome Trust, London, United Kingdom., McShane H; The Jenner Institute, University of Oxford, United Kingdom., Morton B; Department of Clinical Sciences, Liverpool School of Tropical Medicine, United Kingdom., Nambiar S; TB Impact Area, International AIDS Vaccine Initiative, New York, New York., Sharma NR; Infectious Disease, Wellcome Trust, London, United Kingdom., Robertson B; Department of Infectious Disease, Imperial College London, United Kingdom., Schrager LK; TB Impact Area, International AIDS Vaccine Initiative, New York, New York., Weller CL; Infectious Disease, Wellcome Trust, London, United Kingdom.
Publikováno v: The Journal of infectious diseases [J Infect Dis] 2024 Aug 16; Vol. 230 (2), pp. e457-e464.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje